michael sitrickLos Angeles crisis and financial PR maven Michael Sitrick is in line for a board seat with Oxis International, the Tampa-based marijuana sector biotech developing immunotherapries to treat cancer.

Sitrick was named to the company's business advisory board, which sets him up to become a board member when the company "uplists" to the Nasdaq stock exchange.

Anthony Cataldo, who took the Orix reins as chairman and CEO last November, praised Sitrick's strategic communications expertise, as well as "a wealth of experience and knowledge in management, corporate governance and value creation."

Sitrick leads L.A.-based Sitrick and Company.

Orix has expresssed a desire to move its shares to the Nasdaq, which requires a rise in its share price.